Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review.

Clin Infect Dis · 2022 · PMC8524637 · PMID 34651164

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Neither lack of comorbidities nor younger age guarantee mild or favorable disease outcomes, suggesting that unknown host factors may be significant determinants of COVID-19 severity.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.